Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ORANGE PARK MEDICAL CENTER, INC.

NPI: 1689611501 · ORANGE PARK, FL 32073 · General Acute Care Hospital · NPI assigned 05/31/2006

$28.68M
Total Medicaid Paid
779,791
Total Claims
669,724
Beneficiaries
195
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPETTUS, JAY (CFO)
NPI Enumeration Date05/31/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 57,273 $758K
2019 151,168 $4.14M
2020 134,167 $3.91M
2021 150,436 $5.33M
2022 154,667 $6.34M
2023 89,105 $4.97M
2024 42,975 $3.23M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 135,699 124,303 $11.67M
99284 Emergency department visit for the evaluation and management, high severity 58,191 50,775 $4.54M
99282 Emergency department visit for the evaluation and management, low to moderate severity 26,163 24,732 $2.17M
99281 Emergency department visit for the evaluation and management, self-limited or minor 10,676 10,090 $1.10M
80053 Comprehensive metabolic panel 20,234 16,876 $785K
70450 Computed tomography, head or brain; without contrast material 6,426 5,507 $753K
74177 Computed tomography, abdomen and pelvis; with contrast material 4,639 4,208 $662K
80048 Basic metabolic panel (calcium, ionized) 14,378 11,693 $610K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 7,962 6,739 $599K
71275 Computed tomographic angiography, chest, with contrast material 2,219 1,982 $399K
74176 Computed tomography, abdomen and pelvis; without contrast material 2,603 2,362 $379K
10060 1,879 1,761 $289K
81003 29,642 26,943 $262K
59025 Fetal non-stress test 5,115 3,818 $238K
84702 4,643 3,664 $217K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 4,852 4,168 $198K
76818 2,670 1,311 $172K
71046 Radiologic examination, chest; 2 views 13,460 12,473 $164K
96361 Intravenous infusion, hydration; each additional hour 1,423 1,311 $143K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1,882 1,770 $132K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,597 1,501 $131K
12001 1,103 1,050 $129K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2,241 471 $123K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 10,883 10,358 $106K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 2,718 2,581 $101K
81001 8,826 7,852 $98K
87210 6,008 5,614 $97K
87070 3,973 3,790 $95K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 12,779 11,497 $93K
86850 1,116 969 $86K
36415 Collection of venous blood by venipuncture 3,332 2,163 $85K
85027 37,165 29,473 $84K
12011 796 748 $83K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,345 2,138 $78K
81025 30,516 27,791 $75K
84112 529 479 $74K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 2,169 1,870 $73K
87430 8,101 7,737 $61K
80305 2,194 1,981 $61K
G0378 Hospital observation service, per hour 4,485 2,612 $60K
72125 Computed tomography, cervical spine; without contrast material 2,285 1,877 $56K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 20,976 18,028 $56K
73610 1,946 1,795 $55K
73130 1,871 1,721 $53K
71045 Radiologic examination, chest; single view 10,079 8,629 $50K
73630 2,089 1,917 $48K
82565 674 554 $48K
A9270 Non-covered item or service 11,551 3,346 $45K
73564 1,799 1,633 $44K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8,279 7,740 $43K
76801 3,908 3,187 $42K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 5,326 4,921 $41K
87086 Culture, bacterial; quantitative colony count, urine 3,946 3,582 $39K
12002 364 340 $39K
73030 1,594 1,393 $32K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 17,347 13,902 $31K
87077 1,842 1,651 $29K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,450 1,147 $28K
93976 1,328 1,225 $25K
73110 845 777 $23K
70486 297 261 $23K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 8,415 7,870 $23K
74018 886 825 $20K
93971 1,298 1,176 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3,464 3,247 $19K
71250 237 192 $19K
76830 Ultrasound, transvaginal 1,770 1,689 $18K
84484 10,347 7,205 $18K
85610 3,245 2,537 $18K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,002 745 $16K
72131 361 308 $16K
J1644 Injection, heparin sodium, per 1000 units 1,626 734 $16K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 199 174 $15K
85730 2,693 2,090 $15K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 201 188 $15K
84703 2,589 2,391 $14K
J1885 Injection, ketorolac tromethamine, per 15 mg 14,419 11,848 $12K
73140 160 153 $11K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 2,954 2,418 $11K
87807 1,487 1,450 $10K
86900 1,762 1,529 $10K
C1769 Guide wire 288 210 $10K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 132 68 $10K
85014 849 739 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,079 882 $9K
88305 Level IV - Surgical pathology, gross and microscopic examination 507 416 $8K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 44 40 $8K
J3010 Injection, fentanyl citrate, 0.1 mg 1,455 1,121 $7K
85379 1,473 1,342 $7K
73590 321 292 $7K
J7030 Infusion, normal saline solution , 1000 cc 8,250 6,749 $7K
86901 2,608 2,301 $6K
80047 151 141 $6K
73090 218 202 $6K
80076 1,265 1,156 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 5,856 4,913 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg 7,792 6,565 $5K
73560 184 153 $5K
73502 341 302 $5K
64400 15 15 $5K
83880 1,746 1,445 $4K
73080 161 149 $4K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 278 217 $4K
96375 Therapeutic injection; each additional sequential IV push 7,654 6,490 $3K
82550 1,458 1,141 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 8,611 6,574 $3K
29125 303 286 $3K
84443 Thyroid stimulating hormone (TSH) 2,418 2,103 $3K
73620 94 90 $3K
83735 2,771 2,032 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,587 1,347 $3K
83690 8,685 7,552 $3K
80061 Lipid panel 1,165 948 $3K
J7120 Ringers lactate infusion, up to 1000 cc 6,538 5,541 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,341 1,201 $3K
72100 192 177 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,837 5,174 $2K
97162 60 45 $2K
73100 65 60 $2K
J1650 Injection, enoxaparin sodium, 10 mg 1,003 523 $2K
87205 74 55 $2K
87040 1,677 1,204 $2K
J3490 Unclassified drugs 17 13 $2K
81015 119 110 $2K
J1815 Injection, insulin, per 5 units 1,067 476 $2K
29515 29 25 $2K
93017 90 80 $2K
83605 1,858 1,491 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 84 68 $2K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 21 18 $2K
70551 Magnetic resonance imaging, brain; without contrast material 17 17 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 2,370 2,115 $1K
69200 14 14 $1K
77067 Screening mammography, bilateral, including computer-aided detection 54 48 $1K
J2270 Injection, morphine sulfate, up to 10 mg 5,449 3,983 $1K
73700 14 13 $1K
76775 16 12 $1K
85018 1,021 894 $1K
90714 1,501 1,382 $1K
93970 142 131 $936.03
83036 Hemoglobin; glycosylated (A1C) 480 401 $826.98
84100 1,281 871 $826.82
84439 190 164 $762.74
72128 13 12 $642.53
80329 671 557 $599.31
80320 794 714 $548.92
J2060 Injection, lorazepam, 2 mg 1,460 1,116 $546.25
97530 Therapeutic activities, direct patient contact, each 15 minutes 28 14 $535.35
J2765 Injection, metoclopramide hcl, up to 10 mg 1,590 1,412 $483.86
72141 15 13 $458.16
72110 25 24 $416.11
J1200 Injection, diphenhydramine hcl, up to 50 mg 2,331 1,919 $414.17
J2550 Injection, promethazine hcl, up to 50 mg 1,664 1,303 $378.79
83615 267 229 $362.26
82248 489 369 $360.92
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 586 490 $345.50
76870 12 12 $307.71
82247 51 37 $288.72
84520 304 261 $280.13
87186 1,708 1,510 $222.60
J8540 Dexamethasone, oral, 0.25 mg 1,234 1,140 $172.02
J0690 Injection, cefazolin sodium, 500 mg 286 238 $171.66
86308 15 15 $164.26
J0500 Injection, dicyclomine hcl, up to 20 mg 293 270 $159.96
76820 234 101 $157.84
J7050 Infusion, normal saline solution, 250 cc 84 69 $156.30
96376 1,219 1,032 $155.55
97163 14 13 $154.56
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 252 182 $146.75
84550 272 234 $134.04
82607 37 25 $120.00
82746 37 25 $120.00
86140 198 181 $113.71
81002 33 29 $80.00
73120 29 25 $39.44
82570 96 81 $23.55
85652 46 37 $8.76
J1630 Injection, haloperidol, up to 5 mg 175 151 $7.40
77063 Screening digital breast tomosynthesis, bilateral 36 32 $0.00
82077 32 29 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 45 36 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 12 12 $0.00
41899 Unlisted procedure, dentoalveolar structures 77 75 $0.00
84450 105 88 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 3,613 3,440 $0.00
82010 39 32 $0.00
84460 106 89 $0.00
00170 Anesthesia for intraoral procedures, including biopsy 60 58 $0.00
J3370 Injection, vancomycin hcl, 500 mg 17 12 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 76 54 $0.00
73070 25 24 $0.00
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 12 12 $0.00
C9113 Injection, pantoprazole sodium, per vial 12 12 $0.00
82977 18 18 $0.00
85048 21 18 $0.00